Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Predicting time to castration resistance in hormone sensitive prostate cancer by a personalization algorithm based on a mechanistic model integrating patient data.

Elishmereni M, Kheifetz Y, Shukrun I, Bevan GH, Nandy D, McKenzie KM, Kohli M, Agur Z.

Prostate. 2016 Jan;76(1):48-57. doi: 10.1002/pros.23099. Epub 2015 Sep 30.

PMID:
26419619
2.

Complex pattern of interleukin-11-induced inflammation revealed by mathematically modeling the dynamics of C-reactive protein.

Kheifetz Y, Elishmereni M, Agur Z.

J Pharmacokinet Pharmacodyn. 2014 Oct;41(5):479-91. doi: 10.1007/s10928-014-9383-z. Epub 2014 Sep 18.

PMID:
25231819
3.

Complex 2B4 regulation of mast cells and eosinophils in murine allergic inflammation.

Elishmereni M, Fyhrquist N, Singh Gangwar R, Lehtimäki S, Alenius H, Levi-Schaffer F.

J Invest Dermatol. 2014 Dec;134(12):2928-2937. doi: 10.1038/jid.2014.280. Epub 2014 Jul 7.

4.

A review of mixed-effects models of tumor growth and effects of anticancer drug treatment used in population analysis.

Ribba B, Holford NH, Magni P, Trocóniz I, Gueorguieva I, Girard P, Sarr C, Elishmereni M, Kloft C, Friberg LE.

CPT Pharmacometrics Syst Pharmacol. 2014 May 7;3:e113. doi: 10.1038/psp.2014.12.

5.

Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integration.

Agur Z, Elishmereni M, Kheifetz Y.

Wiley Interdiscip Rev Syst Biol Med. 2014 May-Jun;6(3):239-53. doi: 10.1002/wsbm.1263. Epub 2014 Mar 6. Review.

PMID:
24604755
6.

Interacting mast cells and eosinophils acquire an enhanced activation state in vitro.

Elishmereni M, Bachelet I, Nissim Ben-Efraim AH, Mankuta D, Levi-Schaffer F.

Allergy. 2013 Feb;68(2):171-9. doi: 10.1111/all.12059. Epub 2012 Dec 4.

PMID:
23205534
7.

Reconsidering the paradigm of cancer immunotherapy by computationally aided real-time personalization.

Kogan Y, Halevi-Tobias K, Elishmereni M, Vuk-Pavlović S, Agur Z.

Cancer Res. 2012 May 1;72(9):2218-27. doi: 10.1158/0008-5472.CAN-11-4166. Epub 2012 Mar 15.

8.

An integrated disease/pharmacokinetic/pharmacodynamic model suggests improved interleukin-21 regimens validated prospectively for mouse solid cancers.

Elishmereni M, Kheifetz Y, Søndergaard H, Overgaard RV, Agur Z.

PLoS Comput Biol. 2011 Sep;7(9):e1002206. doi: 10.1371/journal.pcbi.1002206. Epub 2011 Sep 29.

9.

Predicting outcomes of prostate cancer immunotherapy by personalized mathematical models.

Kronik N, Kogan Y, Elishmereni M, Halevi-Tobias K, Vuk-Pavlović S, Agur Z.

PLoS One. 2010 Dec 8;5(12):e15482. doi: 10.1371/journal.pone.0015482.

10.

Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro.

Elishmereni M, Alenius HT, Bradding P, Mizrahi S, Shikotra A, Minai-Fleminger Y, Mankuta D, Eliashar R, Zabucchi G, Levi-Schaffer F.

Allergy. 2011 Mar;66(3):376-85. doi: 10.1111/j.1398-9995.2010.02494.x. Epub 2010 Oct 26.

PMID:
20977491
11.

CD48: A co-stimulatory receptor of immunity.

Elishmereni M, Levi-Schaffer F.

Int J Biochem Cell Biol. 2011 Jan;43(1):25-8. doi: 10.1016/j.biocel.2010.09.001. Epub 2010 Sep 15. Review.

PMID:
20833258
12.

Ultrastructural evidence for human mast cell-eosinophil interactions in vitro.

Minai-Fleminger Y, Elishmereni M, Vita F, Soranzo MR, Mankuta D, Zabucchi G, Levi-Schaffer F.

Cell Tissue Res. 2010 Sep;341(3):405-15. doi: 10.1007/s00441-010-1010-8. Epub 2010 Aug 5.

PMID:
20686785
13.

DNAM-1: an amplifier of immune responses as a therapeutic target in various disorders.

Elishmereni M, Bachelet I, Levi-Schaffer F.

Curr Opin Investig Drugs. 2008 May;9(5):491-6. Review.

PMID:
18465659
14.

Optimization of interleukin-21 immunotherapeutic strategies.

Cappuccio A, Elishmereni M, Agur Z.

J Theor Biol. 2007 Sep 21;248(2):259-66. Epub 2007 May 18.

PMID:
17574601
15.

Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model.

Cappuccio A, Elishmereni M, Agur Z.

Cancer Res. 2006 Jul 15;66(14):7293-300.

Supplemental Content

Loading ...
Support Center